Pathogenic microbial cell wall polysaccharides

Pathogenic microbial cell wall polysaccharides are complex carbohydrate structures that constitute the outer layers of various bacteria and fungi, serving as critical determinants of structural integrity and virulence (Nature Reviews Microbiology, 2018). These molecules, which include peptidoglycan, lipopolysaccharides (LPS), and capsular polysaccharides, protect microbes from osmotic pressure and host immune defenses such as phagocytosis (StatPearls, 2023). In clinical medicine, these polysaccharides are highly significant as they often function as pathogen-associated molecular patterns (PAMPs) that trigger inflammatory responses (Frontiers in Immunology, 2020). They are the primary components of many successful conjugate vaccines, which link these sugars to carrier proteins to elicit a robust T-cell dependent immune response (CDC, 2022). Furthermore, certain classes of antibiotics, such as glycopeptides and polymyxins, exert their antimicrobial effects by directly binding to these polysaccharide components or their precursors (NCBI Bookshelf, 2023). Targeting these structures is a cornerstone of infectious disease prevention and treatment, although challenges like serotype replacement and endotoxin-mediated toxicity remain (Journal of Clinical Investigation, 2019).

Other names

Microbial surface polysaccharidesCapsular polysaccharidesBacterial glycansCell wall carbohydratesFungal cell wall polysaccharides

Vaccine-mediated induction of opsonizing antibodies (CDC, 2022); Direct binding to Lipid A to disrupt the outer membrane (StatPearls, 2023); Binding to D-Ala-D-Ala precursors to inhibit peptidoglycan synthesis (NCBI Bookshelf, 2023).